drugset / Trial / NCT06254131
Preoperative Ondansetron Lozenge for Prevention of Postoperative Nausea and Vomiting in Caesarean Section
RandomizedParallel-groupOpen-labelPrevention
Summary
The aim of this study is to estimate the effect of preoperative ondansetron lozenge on prevention of postoperative nausea and vomiting in caesarean section.
Timeline
- Start
- 2024-02-10
- Primary completion
- 2024-10-05
- Completion
- 2024-10-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ondansetron | Other / unclassified | 4 mg | Intravenous |
Indications
No indication recorded.